JAK Inhibitor Increases Hair Growth in Alopecia Areata Patients

In two phase 3 trials, baricitinib produced substantial rates of hair growth for patients with alopecia areata, a condition for which there are currently no approved therapies.

Related Keywords

New Haven ,Connecticut ,United States ,Spain ,Zaragoza ,Baja California ,Mexico ,Yale University ,American ,Yolanda Gilaberte Calzada ,Sanofi Genzyme ,Eli Lilly ,Brett King ,Bristol Myers Squibb ,Gilaberte Calzada ,European Academy Of Dermatology ,Pfizer ,Yale University School Of Medicine ,University Hospital Miguel Servet ,Dermatology Service ,Journal Of The American Academy Dermatology ,European Academy ,Alopecia Tool ,Yale University School ,American Academy ,Alopecia Areata ,Alopecia ,Hair Growth ,Europe ,European ,Headache ,Scalp ,